Skip to content
Clinical Trial Events
The Liver Meeting 2026

Talk Debrief track

The Liver Meeting Debrief 2: Basic Science, Hepatitis, Hepatocellular Carcinoma, Cholestatic Liver Disease, Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol-Associated Liver Disease, and MetALD

Mon, Nov 9, 2026 · 8:00–10:30 AM MST Convention Center: General Session, Hall A, Colorado Convention Center

About this session

The debrief sessions summarize the highest impact papers addressing key topics across the field of hepatology presented during The Liver Meeting. A group of original research reports reflecting major advances in hepatology are succinctly reviewed. Debrief 2 addresses basic science research, hepatitis, hepatocellular carcinoma, cholestatic liver disease, metabolic dysfunction–associated liver disease, alcohol-associated liver disease, and MetALD.

Speakers